Skip to main content
Fig. 2 | European Journal of Medical Research

Fig. 2

From: Role of epigenetics in the clinical evolution of COVID-19 disease. Epigenome-wide association study identifies markers of severe outcome

Fig. 2

Manhattan Plot. Manhattan plot showing the distribution of p-values of differentially methylated CpG sites. The ordinate axis represents the negative log10 of the unadjusted p-value of methylation differences between “severe” and control “mild” groups while the abscissa axis is the location of differentially methylated points concerning chromosomes. Dots in blue color represent the 880 significant differentially methylated CpG sites. The dashed red line represents the threshold of significance (False Discovery Rate)

Back to article page